Kestra Medical Technologies, Ltd. financial data

Symbol
KMTS on Nasdaq
Location
3933 Lake Washington Blvd Ne, Suite 200, Kirkland, WA
Fiscal year end
April 30
Latest financial report
10-Q - Q2 2025 - Sep 12, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.4M shares
Common Stock, Shares, Outstanding 51.3M shares
Entity Public Float 0 USD
Common Stock, Value, Issued 51.3M USD
Weighted Average Number of Shares Outstanding, Basic 51.3M shares +158%
Weighted Average Number of Shares Outstanding, Diluted 51.3M shares +158%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 19.4M USD +51.5%
Research and Development Expense 4M USD +17.5%
Operating Income (Loss) -28.9M USD -56.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -25.8M USD -27%
Income Tax Expense (Benefit) 33K USD +371%
Net Income (Loss) Attributable to Parent -25.8M USD -29.9%
Earnings Per Share, Basic -0.5 USD/shares +55.4%
Earnings Per Share, Diluted -0.5 USD/shares +55.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 201M USD +101%
Other Assets, Current 1.62M USD
Assets, Current 221M USD
Property, Plant and Equipment, Net 40.4M USD
Operating Lease, Right-of-Use Asset 2.05M USD
Other Assets, Noncurrent 1.06M USD
Assets 266M USD
Accounts Payable, Current 18.6M USD
Accrued Liabilities, Current 13.7M USD
Liabilities, Current 32.3M USD
Operating Lease, Liability, Noncurrent 3.07M USD
Other Liabilities, Noncurrent 140K USD
Liabilities 82.1M USD
Retained Earnings (Accumulated Deficit) -546M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 184M USD
Liabilities and Equity 266M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26.3M USD -50.1%
Net Cash Provided by (Used in) Financing Activities -1.88M USD -102%
Net Cash Provided by (Used in) Investing Activities -8.23M USD -17%
Common Stock, Shares Authorized 100M shares
Common Stock, Shares, Issued 51.3M shares
Common Stock, Par or Stated Value Per Share 1 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -36.4M USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 202M USD +101%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42M USD +16.6%
Deferred Tax Assets, Valuation Allowance 104M USD +31.4%
Deferred Tax Assets, Gross 111M USD +32.4%
Operating Lease, Liability 3.21M USD
Depreciation 2.03M USD -14.6%
Payments to Acquire Property, Plant, and Equipment 8.17M USD +16%
Lessee, Operating Lease, Liability, to be Paid 4.55M USD
Property, Plant and Equipment, Gross 66.1M USD
Operating Lease, Liability, Current 36K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.36M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 333K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.34M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Deferred Tax Assets, Operating Loss Carryforwards 52.3M USD +51.2%
Unrecognized Tax Benefits 819K USD +5.81%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.45M USD
Operating Lease, Payments 491K USD +198%
Depreciation, Depletion and Amortization 2.03M USD -14.6%
Deferred Tax Assets, Net of Valuation Allowance 6.88M USD +49.7%
Share-based Payment Arrangement, Expense 4.58M USD +1115%